Literature DB >> 21317393

Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.

Joshua T Mattila1, Collin R Diedrich, Philana Ling Lin, Jiayao Phuah, JoAnne L Flynn.   

Abstract

Understanding the early immunologic events accompanying reactivated tuberculosis (TB) in HIV-infected individuals may yield insight into causes of reactivation and improve treatment modalities. We used the cynomolgus macaque (Macaca fascicularis) model of HIV-Mycobacterium tuberculosis coinfection to investigate the dynamics of multifunctional T cell responses and granuloma T cell phenotypes in reactivated TB. CD4(+) and CD8(+) T cells expressing Th1 cytokines (IFN-γ, IL-2, TNF) and Th2 cytokines (IL-4 and IL-10) were followed from latent M. tuberculosis infection to reactivation after coinfection with a pathogenic SIV. Coinfected animals experienced increased Th1 cytokine responses to M. tuberculosis Ags above the latent-response baseline 3-5 wk post-SIV infection that corresponded with peak plasma viremia. Th2 cytokine expression was not Ag specific, but strong, transient IL-4 expression was noted 4-7 wk post-SIV infection. Animals reactivating <17 wk post-SIV infection had significantly more multifunctional CD4(+) T cells 3-5 wk post-SIV infection and more Th2-polarized and fewer Th0-, Th1-polarized CD8(+) T cells during weeks 1-10 post-SIV infection than animals reactivating >26 wk post-SIV infection. Granuloma T cells included Th0-, Th1-, and Th2-polarized phenotypes but were particularly rich in cytolytic (CD107(+)) T cells. When combined with the changes in peripheral blood T cells, these factors indicate that events during acute HIV infection are likely to include distortions in proinflammatory and anti-inflammatory T cell responses within the granuloma that have significant effects on reactivation of latent TB. Moreover, it appears that mycobacteria-specific multifunctional T cells are better correlates of Ag load (i.e., disease status) than of protection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317393      PMCID: PMC3311978          DOI: 10.4049/jimmunol.1003773

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12.

Authors:  A Marchant; A Amedei; A Azzurri; J Vekemans; M Benagiano; C Tamburini; C Lienhardt; T Corrah; K P McAdam; S Romagnani; M M D'Elios; G Del Prete
Journal:  Am J Respir Cell Mol Biol       Date:  2001-02       Impact factor: 6.914

2.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

3.  T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

Authors:  G Mazzarella; A Bianco; F Perna; D D'Auria; E Grella; E Moscariello; A Sanduzzi
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection.

Authors:  Nadia Caccamo; Giuliana Guggino; Simone A Joosten; Giuseppe Gelsomino; Paola Di Carlo; Lucina Titone; Domenico Galati; Marialuisa Bocchino; Alessandro Matarese; Alfredo Salerno; Alessandro Sanduzzi; Willeke P J Franken; Tom H M Ottenhoff; Francesco Dieli
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

7.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

8.  Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection.

Authors:  Saverio V Capuano; Denise A Croix; Santosh Pawar; Angelica Zinovik; Amy Myers; Philana L Lin; Stephanie Bissel; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 9.  Regulation of IL4 gene expression by T cells and therapeutic perspectives.

Authors:  Min Li-Weber; Peter H Krammer
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

10.  Correlates of protective immune response in tuberculous pleuritis.

Authors:  Kripa V Jalapathy; C Prabha; Sulochana D Das
Journal:  FEMS Immunol Med Microbiol       Date:  2004-03-08
View more
  41 in total

1.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

2.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

Review 3.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 4.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

Review 5.  Quest for correlates of protection against tuberculosis.

Authors:  Kamlesh Bhatt; Sheetal Verma; Jerrold J Ellner; Padmini Salgame
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

Review 6.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 7.  Animal models to study Mycobacterium tuberculosis and HIV co-infection.

Authors:  Ming Guo; Wen-Zhe Ho
Journal:  Dongwuxue Yanjiu       Date:  2014-05

Review 8.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

Review 9.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

Review 10.  Modeling tuberculosis in nonhuman primates.

Authors:  Charles A Scanga; JoAnne L Flynn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.